0.00Open0.00Pre Close0 Volume0 Open Interest45.00Strike Price0.00Turnover440.57%IV-42.99%PremiumDec 13, 2024Expiry Date33.93Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9971Delta0.0005Gamma2.32Leverage Ratio-0.0803Theta0.0010Rho2.32Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet